Summary
Background
Women undergoing coronary angiography (CA) due to chest pain are more likely to present with less extensive coronary artery disease (CAD) than men, which might be attributed to different effects of cardiovascular risk factors on coronary atherogenesis between sexes. The aim of the present study was to evaluate sex differences in independent factors associated with obstructive and non-obstructive CAD in a large consecutive cohort of patients undergoing elective CA.
Methods
Data from 7819 patients (2653 women and 5184 men), including cardiovascular risk factors, clinical presentation, CAD severity and treatment decisions were analysed.
Results
Women were older than men (65 ± 11 vs. 63 ± 11 years, p < 0.001); low-density lipoprotein cholesterol (LDL; 125 ± 38 vs. 122 ± 37 mg/dL, p < 0.001) and high-density lipoprotein cholesterol (HDL) cholesterol levels (62 ± 18 vs. 51 ± 15 mg/dL, p < 0.001) were higher in women; and smokers were more frequently men (14.4 vs. 20.1 %, p < 0.001). Men more frequently had an obstructive CAD (41.1 vs. 65.6 %, p < 0.001). Multivariable analyses revealed age, HDL cholesterol, hypercholesterolaemia, diabetes mellitus, arterial hypertension and a positive family history being associated with obstructive CAD in both sexes, whereas smoking was independently associated with obstructive CAD only in women. The association of hypercholesterolaemia with obstructive CAD was stronger in men. For non-obstructive CAD, no sex-specific associated factors could be identified.
Conclusion
The impact of smoking and hypercholesterolaemia on coronary atherosclerosis is different between women and men. This might be taken into account when planning individual interventions to reduce cardiovascular risk.
Zusammenfassung
Hintergrund
Bei Frauen, die sich aufgrund von Brustschmerzen einer Koronarangiographie unterziehen müssen, findet sich im Vergleich zu Männern seltener eine relevante koronare Herzkrankheit (KHK). Dies könnte auf den unterschiedlichen Einfluss kardiovaskulärer Risikofaktoren auf die KHK bei Frauen und Männern zurückzuführen sein. Das Ziel der aktuellen Studie lag darin, geschlechtsspezifische Unterschiede in unabhängig mit signifikanter und nicht-signifikanter KHK assoziierten Faktoren in einem großen konsekutiven Patientenkollektiv, bei dem eine elektive Koronarangiographie durchgeführt wurde, zu untersuchen.
Methoden
Von 7819 Patienten (n = 2653 Frauen, n = 5184 Männer) wurden kardiovaskuläre Risikofaktoren, die klinische Präsentation, die Schwere der KHK und therapeutische Entscheidungen analysiert.
Resultate
Frauen waren älter als Männer (65 ± 11 vs. 63 ± 11 Jahre, p < 0,001), LDL- (125 ± 38 vs. 122 ± 37 mg/dL, p < 0,001) und HDL-Cholesterin Werte (62 ± 18 vs. 51 ± 15 mg/dL, p < 0,001) waren höher bei Frauen, Rauchen fand sich häufiger bei Männern (14,4 vs. 20,1 %, p < 0,001). Bei Männer wurde häufiger eine signifikante KHK diagnostiziert (41,1 vs. 65,6 %, p < 0,001). In multivariablen Analysen waren das Alter, das HDL-Cholesterin, eine Hypercholesterinämie, ein Diabetes mellitus, eine arterielle Hypertonie und eine positive Familienanamnese mit dem Vorliegen einer signifikanten KHK bei beiden Geschlechtern assoziiert. Rauchen war nur bei Frauen unabhängig mit einer signifikanten KHK korreliert. Die Assoziation von Hypercholesterinämie mit einer signifikanten KHK war bei Männern stärker ausgeprägt. Für die nicht-signifikante KHK konnten keine Geschlechtsunterschiede in den unabhängig assoziierten Faktoren identifiziert werden.
Schlussfolgerung
Der Einfluss von Rauchen und Hypercholesterinämie auf eine KHK ist bei Frauen und Männern unterschiedlich. Dies könnte zukünftig bei der Planung von individuellen Interventionen zur Reduktion des kardiovaskulären Risikos berücksichtigt werden.
Similar content being viewed by others
References
Mancini GB, Bates ER, Maron DJ, et al. Quantitative results of baseline angiography and percutaneous coronary intervention in the COURAGE trial. Circ Cardiovasc Qual Outcomes. 2009;2(4):320–7.
Jong P, Mohammed S, Sternberg L. Sex differences in the features of coronary artery disease of patients undergoing coronary angiography. Can J Cardiol. 1996;12(7):671–7.
Bugiardini R, Bairey Merz CN. Angina with “normal” coronary arteries: a changing philosophy. JAMA. 2005;293(4):477–84.
Humphries KH, Pu A, Gao M, et al. Angina with “normal” coronary arteries: sex differences in outcomes. Am Heart J. 2008;155(2):375–81.
Judkins MP. Selective coronary arteriography. I. A percutaneous transfemoral technic. Radiology. 1967;89(5):815–24.
Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206–52.
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26(Suppl. 1):S5–20.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486–97.
Campeau L. The Canadian Cardiovascular Society grading of angina pectoris revisited 30 years later. Can J Cardiol. 2002;18(4):371–9.
Chiamvimonvat V, Sternberg L. Coronary artery disease in women. Can Fam Physician. 1998;44:2709–17.
Daly C, Clemens F, Lopez Sendon JL, et al. Gender differences in the management and clinical outcome of stable angina. Circulation. 2006;113(4):490–8.
Shaw LJ, Shaw RE, Merz CN, et al. Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry. Circulation. 2008;117(14):1787–801.
Kreatsoulas C, Natarajan MK, Khatun R, et al. Identifying women with severe angiographic coronary disease. J Intern Med. 2009;268(1):66–74.
Anand SS, Islam S, Rosengren A, et al. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J. 2008;29(7):932–40.
Ferrari R, Abergel H, Ford I, et al. Gender- and age-related differences in clinical presentation and management of outpatients with stable coronary artery disease. Int J Cardiol. 2012;167:2938–43.
Prescott E, Osler M, Andersen PK, et al. Mortality in women and men in relation to smoking. Int J Epidemiol. 1998;27(1):27–32.
Warren CW, Jones NR, Peruga A, et al. Global youth tobacco surveillance, 2000–2007. MMWR Surveill Summ. 2008;57(1):1–28.
Global Youth Tabacco Survey Collaborative Group. Tobacco use among youth: a cross country comparison. Tob Control. 2002;11(3):252–70.
Currie C, Zanotti C, Morgan A, et al. Social determinants of health and well-being among young people. Health Behaviour in School-aged Children (HBSC) study: international report from the 2009/2010 survey, WHO Regional Office for Europe, Copenhagen. Health Policy Child Adolesc 2012;6:141–147.
Shaw LJ, Bairey Merz CN, Pepine CJ, et al. Insights from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE) study: part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol. 2006;47(3 Suppl.):S4–20.
Petretta M, Costanzo P, Perrone-Filardi P, et al. Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis. Int J Cardiol. 2010;138(1):25–31.
Alber HF, Frick M, Suessenbacher A, et al. Effect of atorvastatin on circulating proinflammatory T-lymphocyte subsets and soluble CD40 ligand in patients with stable coronary artery disease—a randomized, placebo-controlled study. Am Heart J. 2006;151(1):139.
Alber HF, Duftner C, Wanitschek M, et al. Neopterin, CD4+ CD28− lymphocytes and the extent and severity of coronary artery disease. Int J Cardiol. 2009;135(1):27–35.
Alber HF, Wanitschek M, Duftner C, et al. Neopterin: marker of coronary artery disease activity, severity and/or extent in patients with clinically stable angina? Int J Cardiol. 2010;144(1):75–6.
Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342(12):836–43.
Ballantyne CM, Hoogeveen RC, Bang H, et al. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 2004;109(7):837–42.
Alber HF, Wanitschek MM, de Waha S, et al. High-density lipoprotein cholesterol, C-reactive protein, and prevalence and severity of coronary artery disease in 5641 consecutive patients undergoing coronary angiography. Eur J Clin Invest. 2008;38(6):372–80.
Khor LL, Muhlestein JB, Carlquist JF, et al. Sex- and age-related differences in the prognostic value of C-reactive protein in patients with angiographic coronary artery disease. Am J Med. 2004;117(9):657–64.
Garcia-Moll X, Zouridakis E, Cole D, et al. C-reactive protein in patients with chronic stable angina: differences in baseline serum concentration between women and men. Eur Heart J. 2000;21(19):1598–606.
Qasim AN, Budharaju V, Mehta NN, et al. Gender differences in the association of C-reactive protein with coronary artery calcium in type-2 diabetes. Clin Endocrinol (Oxf). 2010;74(1):44–50.
Lakoski SG, Cushman M, Blumenthal RS, et al. Implications of C-reactive protein or coronary artery calcium score as an adjunct to global risk assessment for primary prevention of CHD. Atherosclerosis. 2007;193(2):401–7.
Granot M, Goldstein-Ferber S, Azzam ZS. Gender differences in the perception of chest pain. J Pain Symptom Manage. 2004;27(2):149–55.
Bosner S, Haasenritter J, Hani MA, et al. Gender bias revisited: new insights on the differential management of chest pain. BMC Fam Pract. 2011;12:45.
Hess EP, Perry JJ, Calder LA, et al. Sex differences in clinical presentation, management and outcome in emergency department patients with chest pain. CJEM. 2010;12(5):405–13.
King KM, Ghali WA, Faris PD, et al. Sex differences in outcomes after cardiac catheterization: effect modification by treatment strategy and time. JAMA. 2004;291(10):1220–5.
Petticrew M, McKee M, Jones J. Coronary artery surgery: are women discriminated against? BMJ. 1993;306(6886):1164–6.
Ghali WA, Faris PD, Galbraith PD, et al. Sex differences in access to coronary revascularization after cardiac catheterization: importance of detailed clinical data. Ann Intern Med. 2002;136(10):723–32.
Guru V, Fremes SE, Tu JV. Time-related mortality for women after coronary artery bypass graft surgery: a population-based study. J Thorac Cardiovasc Surg. 2004;127(4):1158–65.
Gitt AK, Bueno H, Danchin N, et al. The role of cardiac registries in evidence-based medicine. Eur Heart J. 2010;31(5):525–9.
Acknowledgement
Prof. Hanno Ulmer, head of the Department of Medical Statistics, Informatics and Health Economics, Innsbruck Medical University, assisted in statistical analyses.
Conflict of interest
All authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Suessenbacher, A., Wanitschek, M., Dörler, J. et al. Sex differences in independent factors associated with coronary artery disease. Wien Klin Wochenschr 126, 718–726 (2014). https://doi.org/10.1007/s00508-014-0602-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00508-014-0602-9